Successful Treatment of Small-Cell Lung Cancer With Irinotecan in a Hemodialysis Patient With End-Stage Renal Disease
The Korean Journal of Internal Medicine
;
: 73-75, 2009.
Article
in English
| WPRIM
| ID: wpr-12975
ABSTRACT
The prognosis of patients with end-stage renal disease has improved with advances in hemodialysis techniques. However, many patients who undergo hemodialysis suffer from various types of cancer. Limited data is available to guide clinical management of these patients who may have impaired renal function. Here, we report our experience with the use of irinotecan for the treatment of a hemodialysis patient with small-cell lung cancer and end-stage renal disease.
Full text:
Available
Index:
WPRIM (Western Pacific)
Main subject:
Camptothecin
/
Follow-Up Studies
/
Renal Dialysis
/
DNA Topoisomerases, Type I
/
Disease-Free Survival
/
Small Cell Lung Carcinoma
/
Kidney Failure, Chronic
/
Lung Neoplasms
/
Antineoplastic Agents, Phytogenic
Type of study:
Observational study
/
Prognostic study
Limits:
Humans
/
Male
Language:
English
Journal:
The Korean Journal of Internal Medicine
Year:
2009
Type:
Article
Similar
MEDLINE
...
LILACS
LIS